Alivus Life Sciences Ltd.
1,130.10-12.9 (-1.13%)
8 Jul, 12:00 AM
Income Statement
Abridged
Understanding Income Statement
Alivus Life Sciences Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Alivus Life Sciences Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Alivus Life Sciences Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
Business Segment Analysis
FY End:
Mar 25
Alivus Life Sciences Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Capex
Manufacturing of API (100.0%)₹ 166.19 Cr
Revenue / Sales
Manufacturing of API (100.0%)₹ 2,386.88 Cr
Assets
Manufacturing of API (100.0%)₹ 3,411.45 Cr
Operating Income
Manufacturing of API (100.0%)₹ 623.80 Cr
Regional Segment Analysis
FY End:
Mar 25
Alivus Life Sciences Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
Outside India (51.7%)₹ 1,234.52 CrWithin India (48.3%)₹ 1,152.37 Cr
Historical Segment Analysis
Track how Alivus Life Sciences Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
Frequently Asked Questions
What is the revenue of Alivus Life Sciences Ltd.?
The latest trailing twelve month revenue of Alivus Life Sciences Ltd. is ₹ 2,551.83 Cr, reflecting a 1-year growth of 6.91% and a 3-year CAGR of 5.69%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Alivus Life Sciences Ltd.?
The latest trailing twelve month net profit (PAT) of Alivus Life Sciences Ltd. is ₹ 564.48 Cr, with a 3-year earnings CAGR of 6.40%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Alivus Life Sciences Ltd.?
The trailing twelve month EBITDA of Alivus Life Sciences Ltd. is approximately ₹ 721.93 Cr (based on an operating margin of 28.29%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Alivus Life Sciences Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Alivus Life Sciences Ltd. is 45.90. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Alivus Life Sciences Ltd.?
The debt-to-equity ratio of Alivus Life Sciences Ltd. stands at 0.02. The interest coverage ratio is 134.39x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Alivus Life Sciences Ltd.?
The estimated book value per share of Alivus Life Sciences Ltd. is 271.48 (derived from a P/B ratio of 4.16 and market price of ₹ 1,130.10), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Alivus Life Sciences Ltd.?
The trailing twelve month operating cash flow of Alivus Life Sciences Ltd. is ₹ 561.01 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Alivus Life Sciences Ltd. report consolidated or standalone financials?
Alivus Life Sciences Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.